Principles and Practice of Allergy 2026: Evidence-Based Coverage Hypersensitivity Mechanisms, Diagnostic Testing, & Immunotherapy for Immunology Fellows

Every allergist has stared at a test result that should have answered the question - and realized it only deepened it.A positive peanut IgE without component data is not a diagnosis; a dual-positive bee and yellow jacket venom panel without Api m 1 and Ves v 5 is not an immunotherapy prescription; an elevated tryptase without a baseline is not confirmation of anaphylaxis - and every one of these misreads changes patient outcomes.This book gives you a systematic framework for converting test results into clinical decisions across every domain of allergy and clinical immunology - not theory, but the five-step reasoning sequence that turns a panel of numbers into the right action at the right time.Inside this book: - The Test-to-Diagnosis Decoder System - a repeatable five-slot framework embedded in every chapter that takes any allergy result from raw data to clinical decision, including the interpretation trap that sends most clinicians in the wrong direction- Component-resolved diagnostics in practice - distinguish Ara h 2 true peanut allergy from Ara h 8 cross-reactive PFAS, Cor a 14 systemic hazelnut risk from Cor a 1 oral allergy, and Ves v 5 genuine yellow jacket sensitization from MUXF3 carbohydrate artifact- Biologic selection across comorbidities - identify which single agent addresses the patient with concurrent severe atopic dermatitis, eosinophilic asthma, CRSwNP, and EoE without a second prescription- Anaphylaxis management beyond epinephrine - refractory protocols, beta-blocker considerations, glucagon timing, and the biphasic observation standards that determine safe discharge- Mastocytosis and mast cell activation - baseline tryptase interpretation, HAT versus ISM distinction, and the indefinite VIT standard that elevated tryptase demands- Immunodeficiency recognition at the allergy visit - the Pneumovax response interpretation, DHR flow cytometry reading, and the five-year diagnostic delay that destroys lung architecture before CVID is ever namedWritten for allergy and immunology fellows, practicing allergist-immunologists, clinical immunologists, pulmonologists, dermatologists, and advanced practitioners who manage type 2 inflammatory disease and immune dysregulation at every level of complexity.